Goldman Sachs
ONCS

Goldman Sachs’s OncoSec Medical Incorporated ONCS Stock Holding History

Goldman Sachs’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,132
Closed -$53K – 6946
2021
Q3 		$53K Buy
+1,132
New +$57.3K ﹤0.01% 6036
2021
Q1 		– Sell
-845
Closed -$120K – 6597
2020
Q4 		$120K Buy
845
+17
+2% +$1.81K ﹤0.01% 5261
2020
Q3 		$62K Buy
+828
New +$64.5K ﹤0.01% 5160
2018
Q3 		– Sell
-142
Closed -$43K – 5939
2018
Q2 		$43K Buy
+142
New +$49.8K ﹤0.01% 5393
2017
Q1 		– Sell
-65
Closed -$18K – 7144
2016
Q4 		$18K Buy
+65
New +$22.3K ﹤0.01% 6676

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Goldman Sachs's ONCS Position: Q4 2021 in Review

Goldman Sachs sold out of OncoSec Medical Incorporated (ONCS) in Q4 2021, closing a stake of 1,132 shares — an estimated $53K sold.

Goldman Sachs first reported a position in ONCS in Q4 2016 and held it in 5 quarters. The position peaked at $120K in Q4 2020. 34 funds tracked by Wall St. Rank hold ONCS as of Q4 2021.

  • Goldman Sachs reported no remaining OncoSec Medical Incorporated position as of Q4 2021 after selling out during the quarter.
  • Goldman Sachs sold 1,132 OncoSec Medical Incorporated shares in Q4 2021, an estimated $53K.
  • Goldman Sachs first reported a position in OncoSec Medical Incorporated in Q4 2016 and held it in 5 quarters.
  • Goldman Sachs's OncoSec Medical Incorporated position peaked at $120K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2021.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.